Download PDF

Other users also viewed these articles

Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting Sara Marsal Barril; Mª Auxiliadora Martin-Martinez; Francisco Javier Blanco-Garcia; Antonio Fernández-Nebro; Rosario García de Vicuña; Jesús Tornero-Molina; Fernando Sánchez-Alonso; Marta Novella-Navarro; Alejandro Escudero-Contreras; Juan José Alegre-Sancho; Ana Urruticoechea-Arana; Maria Sagrario Bustabad-Reyes; Pilar Trenor-Larraz; Trinidad Pérez-Sandoval; Maria Isabel Tevar-Sánchez; Jesús T. Sánchez-Costa; Enrique Raya-Álvarez;
Reumatol Clin. 2022;18:567-73
Analysis of clinical¿analytical characteristics in patients with rheumatoid arthritis and interstitial lung disease: Case¿control study Natalia Mena-Vázquez; Lorena Pérez Albaladejo; Sara Manrique-Arija; Carmen María Romero Barco; Carmen Gómez Cano; Inmaculada Ureña Garnica; Antonio Fernández-Nebro;
Reumatol Clin. 2021;17:197-202
Efficacy and safety of combined therapy with synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: Systematic literature review Jaime Calvo Alén; Trinidad Pérez; Susana Romero Yuste; Iván Ferraz-Amaro; Juan José Alegre Sancho; José Antonio Pinto Tasende; Francisco Maceiras Pan; Juan Carlos Quevedo; M. Vanesa Hernández-Hernández; Cristina Hidalgo Calleja; Alejandro San Martín Álvarez; María Isabel Tevar Sánchez; Raimon Sanmartí;
Reumatol Clin. 2020;16P1:324-32